Patents by Inventor Ralf Zielenski
Ralf Zielenski has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 8927261Abstract: The invention concerns a method for isolating and purifying nucleic acids from a sample and a device that is suitable therefore.Type: GrantFiled: March 1, 2012Date of Patent: January 6, 2015Assignee: Roche Molecular Systems, Inc.Inventors: Dirk Block, Ruediger Haenel, Joerg Kleiber, Manuela Poignee-Heger, Thomas Walter, Ralf Zielenski
-
Publication number: 20120152818Abstract: The invention concerns a method for isolating and purifying nucleic acids from a sample and a device that is suitable therefore.Type: ApplicationFiled: March 1, 2012Publication date: June 21, 2012Applicant: ROCHE MOLECULAR SYSTEMS, INC.Inventors: Dirk Block, Ruediger Haenel, Joerg Kleiber, Manuela Poignee-Heger, Thomas Walter, Ralf Zielenski
-
Patent number: 8158349Abstract: The invention concerns a method for isolating and purifying nucleic acids from a sample and a device that is suitable therefore.Type: GrantFiled: January 14, 2011Date of Patent: April 17, 2012Assignee: Roche Molecular Systems, Inc.Inventors: Dirk Block, Ruediger Haenel, Joerg Kleiber, Manuela Poignee-Heger, Thomas Walter, Ralf Zielenski
-
Publication number: 20110137020Abstract: The invention concerns a method for isolating and purifying nucleic acids from a sample and a device that is suitable therefore.Type: ApplicationFiled: January 14, 2011Publication date: June 9, 2011Applicant: ROCHE MOLECULAR SYSTEMS, INC.Inventors: Dirk Block, Ruediger Haenel, Joerg Kleiber, Manuela Poignee-Heger, Thomas Walter, Ralf Zielenski
-
Patent number: 7897378Abstract: The invention concerns a method for isolating and purifying nucleic acids from a sample and a device that is suitable therefore.Type: GrantFiled: February 7, 2005Date of Patent: March 1, 2011Assignee: Roche Molecular Systems, Inc.Inventors: Dirk Block, Ruediger Haenel, Joerg Kleiber, Manuela Poignee-Heger, Thomas Walter, Ralf Zielenski
-
Patent number: 7491495Abstract: The present invention is directed to a method for adsorbing, i.e. non-covalently binding, nucleic acids to a solid phase using a two-step procedure. Furthermore, the present invention pertains to a method for isolating nucleic acids from a biological sample. In the first step of the procedure, lysis is effected by mixing the biological sample with an aqueous lysis buffer containing a chaotropic agent and incubating the mixture; in the second step, the concentration of the chaotropic agent in the mixture is increased and the mixture is contacted with the solid phase, whereby the nucleic acids in the liquid phase is adsorbed to the solid phase.Type: GrantFiled: February 18, 2005Date of Patent: February 17, 2009Assignee: Roche Diagnostics Operations, Inc.Inventors: Ralf Zielenski, Klaus Geissler, Thomas Walter
-
Patent number: 7329491Abstract: A method for purification of a nucleic acid comprising the steps of (a) adsorbing on a substrate the nucleic acid from a composition containing (i) an aqueous buffer, (ii) salts in a high concentration, (iii) a water-miscible, non-acidic organic compound, and (iv) the nucleic acid; (b) optionally washing with a washing solution the substrate with the adsorbed nucleic acid; (c) contacting the substrate with the adsorbed nucleic acid with a solution containing salts in a lower concentration compared to the composition of step (a), thereby desorbing the nucleic acid from the substrate; (d) separating the solution with the desorbed nucleic acid from the substrate, thereby purifying the nucleic acid; and optionally (e) precipitating the desorbed nucleic acid from the solution of step (d) and isolating the precipitated nucleic acid, thereby further purifying the nucleic acid.Type: GrantFiled: October 12, 2004Date of Patent: February 12, 2008Assignee: Roche Diagnostics Operations, Inc.Inventors: Michael Kirchgesser, Frank Bergmann, Thomas Walter, Kurt Weindel, Ralf Zielenski, Emad Sarofim
-
Patent number: 7300769Abstract: Stabilized aqueous solution of a coenzyme for hydrogen-transferring enzymes characterized in that the solution contains NAD, NADP or a derivative thereof in an oxidized or reduced form and one or several organic compounds or salts thereof having a pKa value between 1.5 and 6.0 and/or a nitrogen compound of the general formula in which the residues R1, R2 and R3 are the same or different and denote hydrogen, or a saturated or unsaturated alkyl or aryl group as well as the use of the solution to determine dehydrogenases in particular lactate dehydrogenase or substrates thereof.Type: GrantFiled: February 11, 2005Date of Patent: November 27, 2007Assignee: Roche Diagnostics Operations, Inc.Inventor: Ralf Zielenski
-
Publication number: 20050214926Abstract: The present invention is directed to a method for adsorbing, i.e. non-covalently binding, nucleic acids to a solid phase using a two-step procedure. Furthermore, the present invention pertains to a method for isolating nucleic acids from a biological sample. In the first step of the procedure, lysis is effected by mixing the biological sample with an aequous lysis buffer containing a chaotropic agent and incubating the mixture; in the second step, the concentration of the chaotropic agent in the mixture is increased and the mixture is contacted with the solid phase, whereby the nucleic acids in the liquid phase is adsorbed to the solid phase.Type: ApplicationFiled: February 18, 2005Publication date: September 29, 2005Inventors: Ralf Zielenski, Klaus Geissler, Thomas Walter
-
Publication number: 20050208548Abstract: The invention concerns a method for isolating and purifying nucleic acids from a sample and a device that is suitable therefore.Type: ApplicationFiled: February 7, 2005Publication date: September 22, 2005Applicant: ROCHE MOLECULAR SYSTEMS, INCInventors: Dirk Block, Ruediger Haenel, Joerg Kleiber, Manuela Poignee-Heger, Thomas Walter, Ralf Zielenski
-
Publication number: 20050202487Abstract: The present invention is directed to methods and kits for isolation of bacteria from biological samples. In such methods antibodies specific for eukaryotic cells, which are deficient in a bacteria-binding Fc-terminus, are used for separating eukaryotic cells from biological samples.Type: ApplicationFiled: March 1, 2005Publication date: September 15, 2005Applicant: ROCHE MOLECULAR SYSTEMS, INC.Inventors: Juergen Klepp, Peter Kaspar, Ralf Zielenski, Reiner Schlipfenbacher
-
Publication number: 20050136505Abstract: Stabilized aqueous solution of a coenzyme for hydrogen-transferring enzymes characterized in that the solution contains NAD, NADP or a derivative thereof in an oxidized or reduced form and one or several organic compounds or salts thereof having a pKa value between 1.5 and 6.0 and/or a nitrogen compound of the general formula in which the residues R1, R2 and R3 are the same or different and denote hydrogen, or a saturated or unsaturated alkyl or aryl group as well as the use of the solution to determine dehydrogenases in particular lactate dehydrogenase or substrates thereof.Type: ApplicationFiled: February 11, 2005Publication date: June 23, 2005Inventor: Ralf Zielenski
-
Publication number: 20050079535Abstract: A method for purification of a nucleic acid comprising the steps of (a) adsorbing on a substrate the nucleic acid from a composition containing (i) an aqueous buffer, (ii) salts in a high concentration, (iii) a water-miscible, non-acidic organic compound, and (iv) the nucleic acid; ( b) optionally washing with a washing solution the substrate with the adsorbed nucleic acid; (c) contacting the substrate with the adsorbed nucleic acid with a solution containing salts in a lower concentration compared to the composition of step (a), thereby desorbing the nucleic acid from the substrate; (d) separating the solution with the desorbed nucleic acid from the substrate, thereby purifying the nucleic acid; and optionally (e) precipitating the desorbed nucleic acid from the solution of step (d) and isolating the precipitated nucleic acid, thereby further purifying the nucleic acid.Type: ApplicationFiled: October 12, 2004Publication date: April 14, 2005Inventors: Michael Kirchgesser, Frank Bergmann, Thomas Walter, Kurt Weindel, Ralf Zielenski, Emad Sarofim
-
Patent number: 6322993Abstract: The invention concerns a method and reagent for the determination of lipase in the presence of a colour substrate and at least one N-substituted carboxylic acid amide derivative or a compound of the general formula (I) or (Ia) in which R1 and R2 independently of one another represent hydrogen or a saturated or unsaturated, substituted or unsubstituted hydrocarbon residue with 2 to 24 carbon atoms, Z denotes a saturated or unsaturated, substituted, cyclic or straight-chained hydrocarbon residue with 1 to 10 carbon atoms, X represents an atom or a group of atoms with positive charge and n is a number from 1 to 3. Tetra-sodium-N-(1,2-dicarboxylethyl)-N-alkylsulfosuccinamide or a mixture containing such a compound has proven to be particularly advantageous for the elimination of unspecific reactions in the determination of lipase in a biological sample.Type: GrantFiled: May 8, 1998Date of Patent: November 27, 2001Assignee: Roche Diagnostics GmbHInventors: Lieselotte Schelong, Ralf Zielenski, Urban Prinzing
-
Publication number: 20010044128Abstract: Stabilized aqueous solution of a coenzyme for hydrogen-transferring enzymes characterized in that the solution contains NAD, NADP or a derivative thereof in an oxidized or reduced form and one or several organic compounds or salts thereof having a pKa value between 1.5 and 6.Type: ApplicationFiled: January 12, 2001Publication date: November 22, 2001Inventor: Ralf Zielenski
-
Patent number: 6162615Abstract: Stabilized aqueous coenzyme solutions which contain up to ca. 60 mM of a heavy metal salt and optionally a complexing agent in a defined ratio to the heavy metal salt as well as their use for the determination of dehydrogenases in particular lactate dehydrogenase or corresponding substrates in an alkaline environment.Type: GrantFiled: October 16, 1997Date of Patent: December 19, 2000Assignee: Roche Diagnostics GmbHInventor: Ralf Zielenski